Global Primary Cells Market

The global primary cells market share report exhibits a strong industry growth between 2023 and 2030.

Market Research Future (MRFR) reports that the Primary Cells Market Size was valued at USD 0.6 billion in 2022 and is projected to grow from USD 0.66 Billion in 2023 to USD 1.199 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.40% during the forecast period (2023 - 2030).

Advanced and safe mechanical or enzymatic method are used to isolate cells from human or blood cells. Primary cells are engaged in a vast category of cell-based research owing to their pertinent cellular functions.

Increased research activities focused on biopharmaceutical discovery and biotechnology, increased investment in cancer research, growing demand for monoclonal antibodies and higher healthcare expenditure are some of the key factor influencing the global primary cells market. Primary human cells are preferred over cell lines which also remains a positive factor. Unlike endothelial cell lines, endothelial cells retain most functional markers. Primary cells being a novel technology is relatively more expensive. At the same time, issue of cell contamination is yet to be effectively addressed.

Segmental Overview

MRFR’s report includes an in-depth segmental analysis of the global primary cell market based on type, origin and end user.

Based on type, the market has been segmented into animal primary cells and human primary cells. Based on origin, the market has been segmented into hematopoietic cells, liver cells, renal cells, skeletal and muscle cells, skin cells, gastrointestinal cells, lung cells, heart and others. Based on end-user, the market has been segmented into life science research companies and research institutes.

Global Primary Cells Market: Regional Segmentation

Based on region, the market has been segmented into Europe, Americas, the Middle East and Africa (MEA), and Asia Pacific (APAC). The Americas cells market cover both South America and North America. The Europe primary cells market covers Eastern Europe and Western Europe. Key countries covered in the Asia Pacific primary cells market include China, South Korea, Japan, Australia, and India. In terms of revenue, North America and South America collectively dominate the global primary cells market. Some of the key factors supporting the growth of the market in Americas include strong government backing for RD, easy access to latest medical technologies and increased prevalence of cancer.

Europe in holds the second spot in terms of value. Healthcare remains a major area of focus for the EU. Over the years, several policies have been launched to improve health care services in the region. Advanced countries in Europe present attractive growth opportunities for market players.

APAC is viewed as an emerging market for primary cells. The healthcare sector in APAC is witnessing tremendous growth, which is translating into opportunities for market players. Rising number of cancer cases, introduction favourable policies and pharmaceutical outsourcing are some of the factors supporting the market growth in APAC. Spending on medical science RD institutes have surged in countries such as China and India, which is paving the way for the market to growth. The market in MEA is also expected to grow at a healthy pace but from a lower base. Many of the countries in MEA face issues such as underdeveloped healthcare infrastructure, limited access to services, etc.

Competitive Landscape  

Some of the leading companies focused in the global primary cells market trends report are, Cell Biologics (US), ZenBio, Inc. (US), ALLCells (US), Axol Biosciences (UK), Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), American Type Culture Collection (ATCC) (US), Promocell (Germany) and STEMCELL Technologies (Canada).

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com